## LRCX: Lam Research Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_10 2.2% below STRENGTH zone (3.0-6.0%); PEG 1.99 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($149.92)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Lam Research Corp. stock outperforms competitors despite losses on the day**
- Source: MarketWatch | 20251217T163000 | Neutral | Relevance: 100%
- Lam Research Corp. (LRCX) shares fell 5.07% to $154.98 on Wednesday, marking its second consecutive day of losses. Despite this decline, the stock outperformed the broader market, as the S&P 500 Index and Dow Jones Industrial Average also experienced significant losses.

**2. Sanders Morris Harris LLC Acquires New Position in Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251217T130934 | Somewhat-Bullish | Relevance: 100%
- Sanders Morris Harris LLC has acquired a new position in Lam Research Corporation, purchasing 42,420 shares valued at approximately $5.68 million, making it their 18th largest holding. Lam Research recently surpassed quarterly earnings and revenue estimates, issuing positive Q2 2026 guidance. While institutional ownership is high at 84.61% and analysts rate it a "Moderate Buy," insiders have sold a significant number of shares recently.

**3. Lam Research Corporation $LRCX Shares Bought by Aaron Wealth Advisors LLC**
- Source: MarketBeat | 20251216T080837 | Bullish | Relevance: 100%
- Aaron Wealth Advisors LLC significantly increased its stake in Lam Research Corporation ($LRCX) by 90.9% in Q3, acquiring an additional 11,612 shares to hold a total of 24,382 shares valued at approximately $3.27 million. This move comes as Lam Research exceeded Q3 estimates and analysts maintain a "Moderate Buy" consensus rating with an average target price of $156.21. The article also details other institutional investor activities, analyst forecasts, and recent insider transactions for the semiconductor company.

**4. Lam Research Names Top Teams In India Systems Engineering Challenge**
- Source: SMEStreet | 20251216T070759 | Bullish | Relevance: 100%
- Lam Research has announced the winners of its annual Lam Research Challenge 2025, a systems engineering competition for semiconductor equipment manufacturing students in India. The competition, now in its second year, attracted nearly 7000 students and aims to foster future talent for the semiconductor industry by providing hands-on experience in systems engineering. The top three teams were from Maharaja Agrasen Institute of Technology, Indian Institute of Technology, Guwahati, and National Institute of Technology, Calicut.

**5. Lam Research Announces Winners of Annual Collegiate Challenge**
- Source: The Hans India | 20251217T153303 | Bullish | Relevance: 100%
- Lam Research Corp. (Nasdaq: LRCX) announced the winners of its annual Lam Research Challenge 2025, a systems engineering competition in the semiconductor equipment manufacturing industry. The challenge, in its second year, attracted nearly 7000 students from 474 colleges, aiming to foster future talent for the semiconductor industry through problem-solving, innovation, and hands-on experience. The top prize went to a team from Maharaja Agrasen Institute of Technology.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 5, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | B. Riley Securi | $195 | $180 | +8% |
| 2025-12-17 | Mizuho | $200 | $170 | +18% |
| 2025-12-15 | Jefferies | $200 | $175 | +14% |
| 2025-12-02 | Morgan Stanley | $158 | $137 | +15% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | B. Riley Securi | main | Buy |
| 2025-12-17 | Mizuho | main | Outperform |
| 2025-12-15 | Jefferies | main | Buy |
| 2025-12-02 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 12 ($2.00M) |
| Sells | 6 ($14.54M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+0.3%)
- Blackrock Inc.: 9.9% (+1.7%)
- JPMORGAN CHASE & CO: 4.8% (+47.4%)
- State Street Corpora: 4.8% (+0.4%)
- Geode Capital Manage: 2.7% (-0.5%)

### Key Risks

1. Heavy insider selling: $15M sold (6 transactions in 90 days).
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 5 raises (avg +12%) could attract flows.
- Momentum building: MRS_10 improving +1.5% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.99 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 62%, ROA 20%, margin 30%). Balance sheet: strong liquidity (2.2x), $1.6B free cash flow. Analyst sentiment positive (5 raises, avg +12%). Insider selling cluster ($14.5M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $207.7B |
| Beta | 1.78 |
| 52W Range | $56.32 - $169.69 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.99 |
| Forward P/E | 29.3 |
| Current P/E | 34.0 |
| YoY Growth | 16.0% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from 0.7% to 2.2% (+1.5% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.8pp (needs >3.0% for momentum thesis). MRS_5 at 2.0% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.22% (CS: 70) | Neutral |
| RSI_14 | 56.3 | Neutral |
| MACD Histogram | -0.18 | Bearish |
| vs SMA20 | 1.043x | Above |
| vs SMA50 | 1.071x | Above |
| vs SMA200 | 1.524x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $164.70
- **Stop Loss:** $149.92 (9.0% risk)
- **Target:** $179.48 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 64
- **Position Value:** $10,540.80
- **Portfolio %:** 10.54%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-01-28 (Est: $1.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.22 | $1.26 | +3.3% |
| 2025Q2 | $1.21 | $1.33 | +10.4% |
| 2025Q1 | $1.00 | $1.04 | +4.1% |
| 2024Q4 | $0.88 | $0.91 | +3.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*